NVOS
Income statement / Annual
Last year (2024), Novo Integrated Sciences, Inc.'s total revenue was $13.29 M,
an increase of 5.75% from the previous year.
In 2024, Novo Integrated Sciences, Inc.'s net income was -$16.13 M.
See Novo Integrated Sciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
08/31/2024 |
08/31/2023 |
08/31/2022 |
08/31/2021 |
08/31/2020 |
08/31/2019 |
08/31/2018 |
08/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$13.29 M
|
$12.57 M
|
$11.74 M
|
$9.31 M
|
$7.86 M
|
$9.42 M
|
$8.89 M
|
$7.96 M
|
$7.18 M
|
$7.47 M
|
| Cost of Revenue |
$7.55 M |
$7.62 M |
$6.94 M |
$5.48 M |
$4.80 M |
$5.90 M |
$5.47 M |
$4.99 M |
$4.67 M |
$4.76 M |
| Gross Profit |
$5.74 M |
$4.95 M |
$4.80 M |
$3.82 M |
$3.06 M |
$3.52 M |
$3.42 M |
$2.98 M |
$2.51 M |
$2.71 M |
| Gross Profit Ratio |
0.43 |
0.39 |
0.41 |
0.41 |
0.39 |
0.37 |
0.38 |
0.37 |
0.35 |
0.36 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$14.04 M
|
$13.49 M
|
$14.36 M
|
$8.09 M
|
$7.29 M
|
$4.02 M
|
$4.88 M
|
$3.03 M
|
$2.36 M
|
$2.93 M
|
| Selling & Marketing
Expenses |
$17,137.00
|
$15,149.00
|
$20,702.00
|
$7,525.00
|
$4,921.00
|
$39,931.00
|
$109,295.00
|
$59,026.00
|
$25,610.00
|
$63,757.00
|
| Selling, General &
Administrative Expenses |
$14.06 M
|
$13.51 M
|
$14.39 M
|
$8.10 M
|
$7.29 M
|
$4.06 M
|
$4.99 M
|
$3.09 M
|
$164,887.00
|
$2.99 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$21,900.00 |
-$194,055.00 |
$72,080.00 |
$0.00 |
$0.00 |
$0.00 |
$34,000.00 |
| Operating Expenses |
$14.06 M |
$13.51 M |
$14.39 M |
$8.10 M |
$7.29 M |
$4.06 M |
$4.99 M |
$3.09 M |
$164,887.00 |
$401,573.00 |
| Cost And Expenses |
$21.61 M |
$21.13 M |
$21.32 M |
$13.58 M |
$12.09 M |
$9.96 M |
$10.46 M |
$8.08 M |
$164,887.00 |
$401,573.00 |
| Interest Income |
$202,525.00 |
$9,027.00 |
$169,088.00 |
$45,687.00 |
$33,627.00 |
$154,793.00 |
$16,702.00 |
$34,139.00 |
$0.00 |
$0.00 |
| Interest Expense |
-$652,398.00 |
$5.12 M |
$7.57 M |
$165,003.00 |
$156,662.00 |
$222,155.00 |
$564,467.00 |
$554,657.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$0.00
|
$2.30 M
|
$3.02 M
|
$2.37 M
|
$1.99 M
|
$311,865.00
|
$73,447.00
|
$101,664.00
|
$72,586.00
|
$1,011.00
|
| EBITDA |
-$10.08 M
|
-$5.85 M
|
-$22.48 M
|
-$2.58 M
|
-$2.78 M
|
$130,441.00
|
-$1.48 M
|
-$16,693.00
|
-$164,887.00
|
-$277,771.00
|
| EBITDA Ratio |
-0.76 |
-0.47 |
-0.55 |
-0.27 |
-0.38 |
-0.02 |
-0.17 |
-0 |
-0.02 |
-0.05 |
| Operating Income Ratio
|
-0.76
|
-0.68
|
-2.13
|
-0.47
|
-0.54
|
-0.08
|
-0.18
|
-0.01
|
-0.02
|
-0.05
|
| Total Other
Income/Expenses Net |
-$6.05 M
|
-$4.72 M
|
-$8.04 M
|
-$97,416.00
|
-$661,611.00
|
$382,018.00
|
-$547,765.00
|
-$520,518.00
|
$0.00
|
-$2.37 M
|
| Income Before Tax |
-$16.13 M |
-$13.27 M |
-$33.07 M |
-$4.47 M |
-$4.92 M |
-$403,579.00 |
-$2.12 M |
-$633,562.00 |
-$164,887.00 |
-$2.77 M |
| Income Before Tax Ratio
|
-1.21
|
-1.06
|
-2.82
|
-0.48
|
-0.63
|
-0.04
|
-0.24
|
-0.08
|
-0.02
|
-0.37
|
| Income Tax Expense |
$0.00 |
$0.00 |
-$22,302.00 |
$178,115.00 |
-$46,448.00 |
$282,640.00 |
$7,521.00 |
$111,702.00 |
-$72,583.00 |
$2.40 M |
| Net Income |
-$16.13 M |
-$13.21 M |
-$32.85 M |
-$4.46 M |
-$4.92 M |
-$391,984.00 |
-$2.11 M |
-$738,384.00 |
-$164,887.00 |
-$2.77 M |
| Net Income Ratio |
-1.21 |
-1.05 |
-2.8 |
-0.48 |
-0.63 |
-0.04 |
-0.24 |
-0.09 |
-0.02 |
-0.37 |
| EPS |
-0.89 |
-1.3 |
-11.28 |
-1.8 |
-2.13 |
-0.18 |
-1.02 |
-0.42 |
-0.74 |
-13.29 |
| EPS Diluted |
-0.89 |
-1.3 |
-11.28 |
-1.8 |
-2.13 |
-0.18 |
-1.02 |
-0.42 |
-0.74 |
-13.29 |
| Weighted Average Shares
Out |
$18.03 M
|
$10.17 M
|
$2.91 M
|
$2.48 M
|
$2.30 M
|
$2.17 M
|
$2.08 M
|
$1.78 M
|
$223,626.00
|
$208,514.00
|
| Weighted Average Shares
Out Diluted |
$18.03 M
|
$10.17 M
|
$2.91 M
|
$2.48 M
|
$2.30 M
|
$2.17 M
|
$2.08 M
|
$1.78 M
|
$223,626.00
|
$208,514.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
